You are here

restructuring

J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit

J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit

Fierce Biotech

infectious disease

Flag link:

Amid major restructuring, Novartis CEO Narasimhan’s 2022 pay fell by more than a quarter

Amid major restructuring, Novartis CEO Narasimhan’s 2022 pay fell by more than a quarter

Fierce Pharma

Flag link:

Talaris Slashes Workforce, Shifts Focus in Restructuring

Talaris Slashes Workforce, Shifts Focus in Restructuring

BioSpace

Talaris Therapeutics

kidney transplant

Flag link:

Bayer's 3 business units 'perfectly positioned,' trade union says in resistance to potential breakup

Bayer's 3 business units 'perfectly positioned,' trade union says in resistance to potential breakup

Fierce Pharma

Flag link:

Diagnostics companies turn to restructuring in bid to preserve cash: Goldman

Diagnostics companies turn to restructuring in bid to preserve cash: Goldman

Medtech Dive

Guardant Health

Flag link:

Medtronic’s Chan talks patient monitoring spinoff, rise of home care

Medtronic’s Chan talks patient monitoring spinoff, rise of home care

Medtech Dive

patient monitoring

Flag link:

J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries

J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries

Fierce Pharma

Flag link:

5 questions facing emerging biotech in 2023

5 questions facing emerging biotech in 2023

BioPharma Dive

platform companies

Inflation Reduction Act

Flag link:

Novartis sells U.S. rights to five drugs to Harrow for up to $175M

Novartis sells U.S. rights to five drugs to Harrow for up to $175M

Medical Marketing and Media

Flag link:

Months after slimming its R&D focus, Orion realigns stars in top-down organizational restructure

Months after slimming its R&D focus, Orion realigns stars in top-down organizational restructure

Fierce Biotech

Flag link:

Novartis to lay off 400 at Dublin campus amid global restructuring

Novartis to lay off 400 at Dublin campus amid global restructuring

Fierce Pharma

Flag link:

Another biotech grabs the axe, chopping R&D in a major reorganization as drug sales disappoint

Another biotech grabs the axe, chopping R&D in a major reorganization as drug sales disappoint

Endpoints

Heron Therapeutics

Flag link:

Novartis Reveals Restructure will Cost up to 8,000 Jobs

Novartis Reveals Restructure will Cost up to 8,000 Jobs

BioSpace

Flag link:

Amarin turns to job cuts as generics challenge its heart pill

Amarin turns to job cuts as generics challenge its heart pill

BioPharma Dive

Flag link:

Praxis wields the axe as lead depression drug fails

Praxis wields the axe as lead depression drug fails

Pharmaforum

Praxis Precision Medicines

major depressive disorder

Flag link:

Amarin CFO resigns amid cost-cutting measures, staff reduction of 40%

Amarin CFO resigns amid cost-cutting measures, staff reduction of 40%

Endpoints

Flag link:

After layoffs, BridgeBio turns to dealmaking for up to 6 drugs

After layoffs, BridgeBio turns to dealmaking for up to 6 drugs

Fierce Biotech

BridgeBio Pharma

Flag link:

‘Tis the Season: Job Cuts and C-Suite Shifts at Novartis, BridgeBio and Nektar

‘Tis the Season: Job Cuts and C-Suite Shifts at Novartis, BridgeBio and Nektar

BioSpace

Flag link:

Thousands of layoffs planned as part of Novartis restructuring — report

Thousands of layoffs planned as part of Novartis restructuring — report

Endpoints

Flag link:

Feeling Blue: bluebird bio cuts staff by 30%, prepares for FDA decision

Feeling Blue: bluebird bio cuts staff by 30%, prepares for FDA decision

BioSpace

Flag link:

Pages